Terbutaline Global Buyers List: A Strategic Guide for API Exporters and Procurement Teams
Understanding the Terbutaline Global Trade Landscape
Terbutaline, a short-acting beta-2 adrenergic receptor agonist, remains one of the most widely traded bronchodilator molecules in the global pharmaceutical supply chain. Despite facing regulatory scrutiny in certain obstetric applications, the molecule continues to see consistent demand across respiratory care, emergency medicine, and hospital settings worldwide.
For API exporters, traders, and procurement professionals, having access to a reliable terbutaline global buyers list is not merely a competitive advantage—it is a prerequisite for market entry and sustainable growth. This guide synthesizes verified B2B trade data, regulatory intelligence, and market analysis to provide a comprehensive view of who is buying terbutaline, where demand is concentrated, and how to navigate this specialized segment of the pharmaceutical trade.
Terbutaline at a Glance: Chemical and Trade Identifiers
Before exploring buyer landscapes, establishing the foundational identifiers for terbutaline is essential for accurate trade documentation and customs classification.
| Parameter | Detail |
|---|---|
| CAS Registry Number (Terbutaline Sulfate) | 23031-32-5 |
| CAS Registry Number (Free Base) | 23031-25-6 |
| HS Code (Primary) | 29225090 |
| Alternative HS Codes | 29225000, 2942000000 |
| Primary Dosage Forms | Tablets, Injection, Inhalation/Nebulizer Solution, Aerosol |
| Therapeutic Categories | Asthma, COPD, Bronchospasm, Preterm Labor (off-label) |
The HS code 29225090—covering oxygen-function amino-compounds and related pharmaceutical intermediates—is the most frequently recorded classification in global terbutaline trade documentation. Exporters should verify the specific HS code requirements of destination countries, as some markets apply alternative classifications based on product form or end-use designation.
Market Size and Demand Drivers
The global terbutaline market was valued at approximately USD 428.0 million in 2025 and is projected to reach USD 594.82 million by 2033, growing at a compound annual growth rate of 4.2% during the forecast period. This steady growth trajectory reflects the molecule’s entrenched position in respiratory care protocols across both developed and emerging healthcare systems.
Several structural factors underpin continued demand:
Respiratory Disease Burden: An estimated 300–350 million individuals worldwide are affected by asthma and chronic obstructive pulmonary disease, creating a vast and sustained patient pool requiring bronchodilator therapy. Terbutaline’s rapid onset of action and cost-effectiveness make it particularly valuable in emergency and acute care settings.
Generic Manufacturing Expansion: As terbutaline has long been off-patent, generic manufacturers across India, China, and other pharmaceutical hubs have expanded production capacity to meet institutional and retail demand. This has created a parallel demand stream for terbutaline API among formulation manufacturers in multiple geographies.
National Essential Medicines Inclusion: Terbutaline remains listed on national essential medicines lists and standard treatment guidelines across numerous countries, supporting consistent procurement volumes through centralized and bulk-purchasing programs.
Regional Growth Dynamics: North America dominated the global terbutaline market with a 36.48% revenue share in 2025, while Asia-Pacific is positioned as the fastest-growing region at a 6.1% CAGR, driven by rising air pollution-linked respiratory disorders and expanding healthcare infrastructure.
Key Terbutaline Buyer Regions and Import Activity
Global B2B trade data reveals a highly concentrated import landscape for terbutaline and its sulfate salt. According to verified transaction records, the trade is led by India as the dominant export country, while import activity is concentrated across several key buyer markets.
Primary Importing Countries
| Buyer Country | Market Share (Imports) | Notable Characteristics |
|---|---|---|
| Vietnam | 25.41% | Largest single import destination; active pharmaceutical manufacturing sector |
| Nepal | 15.12% | Significant importer despite smaller market size |
| Turkey | High-volume importer | Major formulation manufacturing hub for regional export |
| China | Active importer | Growing demand for generic API sourcing |
Vietnam has emerged as the leading import destination for terbutaline sulfate API, accounting for 25.41% of global import share according to B2B transaction tracking. Vietnam-based pharmaceutical companies such as Hanoi CPC1 Pharmaceutical Joint Stock Company have been documented importing terbutaline sulphate USP from Indian suppliers, with transaction records showing consistent purchasing activity.
Nepal holds the second-largest import share at 15.12%, underscoring the demand for terbutaline in South Asian markets where respiratory disease prevalence is high and pharmaceutical manufacturing relies on API imports.
Turkey represents a strategically significant buyer market, with verified transactions involving API shipments from Indian manufacturers. Turkish pharmaceutical companies, including AstraZeneca’s local entity and domestic formulators, import terbutaline sulphate for both human and veterinary applications. The country serves as a regional manufacturing and distribution hub for the broader Middle East and North Africa region.
China maintains active import activity for terbutaline, with buyers such as Nanjing Belger Pharmaceuticals documented purchasing terbutaline sulphate USP from international suppliers.
Building a Terbutaline Global Buyers List: Verified Buyer Profiles
A practical terbutaline global buyers list must be built from verifiable trade data rather than speculative directories. The following buyer profiles are derived from documented import transactions and should serve as a starting point for suppliers seeking to establish commercial relationships.
Documented Terbutaline Buyers (by Country)
Vietnam
- Hanoi CPC1 Pharmaceutical Joint Stock Company — Repeated importer of terbutaline sulphate USP from Indian suppliers including Shimoga Chemicals; transaction volumes recorded in hundreds of kilograms.
China
- Nanjing Belger Pharmaceuticals — Active buyer of terbutaline sulphate USP, with trade records showing consistent import activity.
- Wang Xia Dan — Documented importer of terbutaline sulphate, though with limited recent transaction history.
Kazakhstan
- KPC Medservice Plus LLP — High-volume pharmaceutical importer with diverse product portfolio including terbutaline, salbutamol, and salmeterol combinations.
- Inkar — Documented importer of pharmaceutical formulations containing terbutaline.
Ukraine
- Glenmark Ukraine LLC — Active importer of terbutaline-containing pharmaceutical products, including combination expectorant formulations.
Sri Lanka
- Innogen Lanka Pvt Ltd. — Importer of terbutaline tablets BP 2.5mg, indicating demand for finished dosage forms alongside API.
Egypt
Jordan
- Naratech Pharma Consultancy — Importer of terbutaline sulfate reference standards, serving the quality control and analytical testing segment.
United Arab Emirates
- Glenmark IMP EXP — Regional importer and distributor of terbutaline-containing pharmaceutical products.
Pakistan
Turkey
- AstraZeneca İlaç Sanayi ve Ticaret Ltd. Şti. — Major multinational entity with documented terbutaline API and finished product import activity.
- Avixa İlaç San. ve Tic. A.Ş. — Turkish pharmaceutical manufacturer with terbutaline import records.
This list represents a snapshot of verified trade activity. A comprehensive terbutaline global buyers list should be continuously updated through customs data platforms, bill of lading analysis, and B2B trade intelligence services.
Trade Data Intelligence: How to Access and Interpret Terbutaline Import Records
Professional-grade buyer identification relies on structured trade data rather than anecdotal referrals. Several platforms provide verified terbutaline import-export intelligence:
Pharmaoffer tracks over 800 verified B2B transactions for terbutaline, representing more than 150 exporters and 250 importers across the global supply chain. This data covers pricing benchmarks, transaction volumes, and buyer-supplier relationship mapping.
52wmb.com maintains a terbutaline buyer directory with 832 documented results, including company profiles, transaction histories, and contact information for verified importers. The platform’s data is updated through customs records and bill of lading filings.
Volza provides HSN code-level export-import data, enabling granular analysis of terbutaline shipments by origin, destination, quantity, and declared value. For example, export records to Vietnam under HSN code 29225090 show detailed product descriptions, manufacturer information, and batch-level traceability.
Seair Exim Solutions offers India-specific import data for terbutaline, covering customs declarations under HS code 29420090 and related classifications.
When interpreting trade data, procurement and sales teams should focus on:
- Transaction frequency: Repeated importers indicate established supply chain requirements
- Volume patterns: Seasonal or project-based demand fluctuations
- Supplier concentration: Whether buyers source from single or multiple suppliers
- Price trends: Benchmarking against market averages to inform negotiation strategy
Regulatory Considerations Impacting Terbutaline Trade
Regulatory status significantly influences terbutaline demand patterns and buyer behavior across different markets. Understanding these dynamics is essential for suppliers and buyers alike.
FDA Warning on Preterm Labor Use
The U.S. Food and Drug Administration has issued a boxed warning stating that terbutaline should not be used for prolonged tocolysis (beyond 48–72 hours) and must not be used for maintenance tocolysis in outpatient or home settings. Serious adverse reactions, including maternal death, have been reported following terbutaline administration to pregnant women. The FDA has specifically advised clinicians not to use injectable terbutaline for the prevention or prolonged treatment of preterm labor due to potential serious maternal cardiac problems.
This regulatory restriction has shifted demand dynamics away from obstetric applications in regulated markets while maintaining—and in some cases strengthening—demand for respiratory indications.
European Medicines Agency Actions
The EMA’s Pharmacovigilance Risk Assessment Committee has updated labeling requirements for terbutaline-containing products, with changes to Section 4.4 of the SmPC to reflect updated safety information. Nationally authorized terbutaline products across EU member states remain available, with products such as Bricanyl Turbohaler and terbutaline injection ampoules maintaining marketing authorization.
Implications for Global Buyers
Regulatory divergence creates distinct buyer segments:
- Respiratory care buyers in regulated markets (North America, EU) continue to source terbutaline for asthma and COPD indications, where the molecule retains full approval.
- Hospital and emergency care buyers require injectable and nebulizer formulations for acute bronchospasm management.
- Emerging market buyers may have different regulatory frameworks and clinical practice patterns, potentially including broader indications.
- Veterinary pharmaceutical buyers represent a niche but consistent demand segment, particularly in markets with developed animal health sectors.
Key Terbutaline Manufacturers and Suppliers
Understanding the supply side of the terbutaline market is essential for buyers seeking reliable sourcing partners and for sellers benchmarking competitive positioning.
Global API Manufacturers
The terbutaline sulfate API manufacturing landscape is led by Indian producers, who account for 70–87% of global export share depending on the data source and product specification. Key manufacturers include:
- Brundavan Laboratories Private Limited (India) — Documented exporter with verified B2B transactions to Turkey and other markets.
- Melody Healthcare Pvt. Ltd. (India) — Active exporter with documentation for terbutaline sulfate shipments to Vietnam.
- Shimoga Chemicals (India) — Supplier to Hanoi CPC1 Pharmaceutical in Vietnam, with documented terbutaline sulphate USP transactions.
- Om Pharmaceutical Industries (India) — Multiple documented terbutaline API transactions with Vietnamese buyers.
- Swapnroop Drugs & Pharmaceuticals (India) — Terbutaline API manufacturer serving 25+ international markets from Maharashtra.
- Sihauli Chemicals (India) — Terbutaline sulfate manufacturer and exporter serving Asia, Africa, Europe, and the Americas.
Multinational and Formulation Players
Major pharmaceutical companies with terbutaline product portfolios include AstraZeneca plc (originator of Bricanyl), Teva Pharmaceutical Industries, Hikma Pharmaceuticals, Pfizer, and Viatris. These companies typically source API through qualified supplier networks and maintain rigorous vendor qualification requirements.
Strategic Recommendations for API Exporters Targeting Terbutaline Buyers
1. Prioritize High-Concentration Import Markets
Vietnam, Nepal, Turkey, and China represent the most accessible and high-volume terbutaline import markets based on documented trade flows. Suppliers should develop market-specific strategies:
- Vietnam: Focus on established pharmaceutical manufacturers with consistent import records; ensure compliance with Vietnamese pharmaceutical import regulations.
- Turkey: Position as a reliable alternative or supplementary supplier to existing multinational relationships; emphasize competitive pricing and consistent quality.
- Nepal: Small but high-share market where relationship-based selling and logistical reliability are key differentiators.
- China: Large addressable market requiring patience and regulatory navigation; partner with domestic distributors where appropriate.
2. Leverage Trade Data for Lead Qualification
Rather than purchasing generic buyer lists, suppliers should build targeted prospect databases using customs trade data platforms. Filter for:
- Importers with documented terbutaline transactions in the past 24 months
- Buyers with volume requirements matching your production capacity
- Companies importing from multiple suppliers (indicating openness to new vendors)
- Markets where your regulatory documentation (DMF, CEP, GMP certificates) provides competitive advantage
3. Address Regulatory Documentation Requirements Proactively
Terbutaline buyers in regulated markets typically require:
- Drug Master File (DMF) status in relevant jurisdictions
- Certificate of Suitability (CEP) from EDQM for European markets
- GMP certification from recognized authorities (FDA, EU, WHO)
- Batch-specific documentation including COA, MSDS, and stability data
Suppliers should maintain current documentation and be prepared to provide regulatory support to formulation manufacturers seeking product registration.
4. Develop Segment-Specific Value Propositions
Different buyer segments prioritize different supplier attributes:
- Generic formulation manufacturers prioritize price competitiveness and volume reliability.
- Hospital and institutional buyers emphasize documentation completeness and supply chain consistency.
- Research and reference standard buyers require high-purity material with comprehensive analytical documentation.
- Veterinary pharmaceutical manufacturers may have different specification requirements and regulatory pathways.
Frequently Asked Questions (FAQ)
What is the primary HS code for terbutaline API exports?
The most commonly used HS code for terbutaline sulfate API is 29225090, covering oxygen-function amino-compounds. Some trade records also use 29225000 or 29420090 depending on destination country requirements and product specification.
Which countries are the largest importers of terbutaline?
Vietnam is the largest single import destination by market share (25.41%), followed by Nepal (15.12%), with Turkey and China also representing significant import volumes.
Who are the leading terbutaline API manufacturers?
Indian manufacturers dominate the global terbutaline API supply landscape, including Brundavan Laboratories, Melody Healthcare, Shimoga Chemicals, and Swapnroop Drugs & Pharmaceuticals. AstraZeneca remains the originator brand manufacturer.
Is terbutaline still approved for asthma treatment?
Yes. Terbutaline retains full regulatory approval for asthma, COPD, and bronchospasm indications across major markets. The FDA’s boxed warning specifically addresses off-label use for preterm labor management, not the approved respiratory indications.
How can I access verified terbutaline import-export data?
Professional trade data platforms including Pharmaoffer, 52wmb, Volza, and Seair Exim Solutions provide verified B2B transaction records, customs data, and buyer-supplier mapping for terbutaline.
What documentation do terbutaline buyers typically require?
Standard requirements include Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), GMP certification, Drug Master File (DMF) status, and for European markets, a Certificate of Suitability (CEP) from EDQM.
What is the current market size of the global terbutaline market?
The global terbutaline market was valued at approximately USD 428.0 million in 2025 and is forecast to reach USD 594.82 million by 2033 at a CAGR of 4.2%.
CÔNG TY TNHH DỊCH VỤ THƯƠNG MẠI PHẠM NGUYỄN
PT IMCD INDONESIA
OOO SERENE PHARMA
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORYPRIVATE LI
CÔNG TY TNHH SẢN XUẤT NAVIS VIỆT NAM
ULTRA INTERNATIONAL
ASTRON LTD
M S SIZA INTERNATIONAL PVT LTD
ИП ООО EVRO FARM BIZNES
CÔNG TY TNHH MTV NOVALAB
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
M S BARRETT HODGSON PAKISTAN PVT LTD
PT IFARS PHARMACEUTICAL LABORATORIES
CÔNG TY CỔ PHẦN KHOA HỌC CÔNG NGHỆ T T
AMNEAL PHARMACEUTICALS LLC
ARAGEN LIFE SCIENCES LIMITED
BARRETT HODGSON PAKISTAN PVT LTD
CINCHONA BIOSCIENCES
CÔNG TY CỔ PHẦN DƯỢC PHẨM TRUNG ƯƠNG 2
CÔNG TY CỔ PHẦN DƯỢC PHẨM VĨNH PHÚC
EVRO FARM BIZNES
FRESENIUS KABI ONCOLOGY LIMITED
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE L
PLATINUM PHARMACEUTICALS PRIVATE LIMITED
ROPSOHN THERAPEUTICS SAS
STATE PHARMACEUTICALS CORPORARION
CÔNG TY CỔ PHẦN DƯỢC PHẨM CPC1 HÀ NỘI
CÔNG TY CỔ PHẦN S P M
DHL KEELLS PVT LTD
LABORATORY SCIENTIFIC SUPPLIES PRIVATE LIMITED
LLC EVRO FARM BIZNES
M S FEDRO PHARMACEUTICAL LABS PVT LTD
NOVITIUM LABS PRIVATE LIMITED
QWINJAYA ADITAMA
QWINJAYA ADITAMA PT
SAVINO DEL BENE USA INC
SERENE PHARMA
SIGMA ALDRICH QUIMICA S DE RL DE CV
SUCOPEIA REFERENCESTANDARDS OPC PRIVATE LIMITED
ADCOCK INGRAM LIMITED
AFRIASIA GLOBAL LOGISTICS LTD
BRYON PHARMACEUTICALS PVT LIMITED
CÔNG TY LIÊN DOANH MEYER BPC
CÔNG TY TNHH MEDOCHEMIE VIỄN ĐÔNG
CÔNG TY TNHH MERCK VIỆT NAM
DRUGMAKERS LABORATORIES INC
FAMOUS PACIFIC SHIPPING LANKA PVT
HIKMA PHARMACEUTICALS USA INC
MORISON LIMITED
OOO MEDSOFT PHARMA
PHIL PHARMAWEALTH INC
SAVINO DEL BENE USA NEW JERSEY
SIZA INTERNATIONAL PVT LTD
TATARASA PRIMATAMA
U S GROUP CONSOLIDATOR INC
UNISEL LIMITED
WONDA MED LIMITED
WONDAMED PHARMACY
ZAFA PHARMACEUTICAL LABORATORIES PVT LIMITED
ACE HEALTHCARE PRIVATE LIMITED
AE ALCHEMISTS INC
AMNEAL PHARMACEUTICALS PRIVATE LIMITED
AMNEAL PHARMACEUTICALS PVT LTD
ASTRAZENECA ILAC SANAYI VE TICARET LIMITED SIRKETI
BAJWA PHARMACEUTICALS PVT LIMITED
CÔNG TY CP DƯỢC VẬT TƯ Y TẾ HÀ NAM
CÔNG TY CỔ PHẦN DƯỢC KHOA
CÔNG TY CỔ PHẦN DƯỢC PHẨM AN THIÊN
CÔNG TY CỔ PHẦN DƯỢC PHẨM CÔNG NGHỆ CAO ABIPHA
CÔNG TY CỔ PHẦN DƯỢC PHẨM EURO SANTÉ
CÔNG TY CỔ PHẦN DƯỢC PHẨM HÀ TÂY
CÔNG TY CỔ PHẦN DƯỢC PHẨM MINH DÂN
CÔNG TY CỔ PHẦN DƯỢC PHẨM OPV
CÔNG TY CỔ PHẦN DƯỢC PHẨM VÀ SINH HỌC Y TẾ
CÔNG TY CỔ PHẦN DƯỢC TRANG THIẾT BỊ Y TẾ BÌNH ĐỊNH BIDIPHAR
CÔNG TY CỔ PHẦN NGHIÊN CỨU VÀ SẢN XUẤT DƯỢC PHẨM MERACINE
CÔNG TY TNHH HỢP NHẤT BA CHÍN
CÔNG TY TNHH KHOA HỌC KỸ THUẬT TOÀN CẦU
CÔNG TY TNHH KHOA HỌC NNC
CÔNG TY TNHH THƯƠNG MẠI H B C
CÔNG TY TNHH XUẤT NHẬP KHẨU Y TẾ DELTA
EXPEDITORS INTERNATIONAL OF WASHING
FEDERAL MINISTRY OF HEALTH DIRECTOR
FEDERAL MINISTRY OF HEALTH DIRECTORATE OF INTERNATIONAL HEALTH
FOCUS RULZ PHARMACEUTICALS PRIVATE LIMITED
GENERICS AFRICA LIMITED
INNOGEN LANKA PVT LTD
JAVED CHEMICAL CORPORATION
JSC SERENE PHARMA
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY PRIVATE LIMITED
KENTFARMA ILAC ANONIM SIRKETI
KIMIA TRADING LTDA
KNORS SCIENTIFIC RESEARCH PRIVATE LIMITED
LABORATORY AND ALLIED LIMITED
MELODY HEALTHCARE PRIVATE LIMITED
NIGHTINGALE PHARMACEUTICALS LTD
OBSONS PHARMACEUTICALS
OOO CALYX PHARMA
PHYTO RIKER GIHOC PHARMACEUTICALS COMPANY LIMITED
PLATINUM PHARMACEUTICALS PVT LTD
PT KARUNIA MAKMUR SELARAS
PT MERCK CHEMICALS LIFE SCIENCES
SACHITRA MEDICARE SERVICES P L
SBR GROUP OF COMAPNIES
SHIMOGA CHEMICALS
SIZA INTERNATIONAL
SRI AMAN CORPORINDO
SRI AMAN CORPORINDO PT
STANDARD ANALYTICS
STATE PHARMACEUTICALS CORPORARION OF SRI LANKA
STATE PHARMACEUTICALS CORPORATION
TOTALENERGIES EP NIGERIA LIMITED
ULTRA BIO INSTRUMENTS PRIVATE LIMITED
VEERAM HEALTHCARE U LIMITED
VINRO LANKA
ZAFA PHARMACEUTICAL LABORATORIES PVT LTD
ZENUFA LABORATORIES LIMITED
ООО CHEMO LAB
Conclusion: Building Sustainable Terbutaline Trade Relationships
The terbutaline global buyers list is not a static document—it is a living intelligence asset that must be continuously updated through trade data monitoring, regulatory tracking, and relationship development. The most successful API exporters in this segment combine data-driven prospecting with regulatory expertise and reliable supply chain execution.
For procurement teams, the key takeaway is that supplier diversification and documentation verification remain critical. For suppliers, the opportunity lies in serving the growing demand from Vietnamese, Turkish, and broader Asia-Pacific formulation manufacturers while maintaining the quality standards required by regulated markets.
As the global respiratory disease burden continues to expand—particularly in Asia-Pacific where terbutaline demand is growing fastest—the buyers and sellers who invest in trade intelligence, regulatory compliance, and relationship-building will capture disproportionate value in this essential pharmaceutical segment.


